Skip to content

Research on the diagnosis, differential diagnosis, and prognosis prediction of benign and malignant renal tumors through Ultrasound-related Artificial intelligence and radiomics

Research on the diagnosis, differential diagnosis, and prognosis prediction of benign and malignant renal tumors through Ultrasound-related Artificial intelligence and radiomics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084141
Enrollment
Unknown
Registered
2024-05-11
Start date
2024-05-31
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign and malignant renal tumors

Interventions

benign and malignant renal tumors:Observation study without intervention

Sponsors

The Central Hospital of Wuhan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 90 Years

Inclusion criteria

Inclusion criteria: ? Patients diagnosed with benign and malignant renal tumors in our hospital ; ? Patients who have renal ultrasound examination data within one week before surgery.

Exclusion criteria

Exclusion criteria: ? The ultrasound image is not clear; ? Indeed, most clinical data; ? Combined with other serious chronic diseases or malignant tumors; ? The postoperative follow-up time is less than 12 months.

Design outcomes

Primary

MeasureTime frame
The Ultrasound imaging omics characteristics of renal tumors;Age, Sex, BMI, Past history, size,location and blood flow of renal tumors;Pathological examination results of tumors;

Secondary

MeasureTime frame
Laboratory test results (including blood routine, renal function,ESR and Tumor markers etc.);Other imaging omics features of renal tumors (CT and MRI);

Countries

China

Contacts

Public ContactYanyun Shu

Department of Ultrasound, The Central Hospital of Wuhan

shuyanyun0406@163.com+86 130 0631 3885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026